FDA Approved: INDOCIN — Supplemental Application (Zyla Life Sciences US LLC)

View source ↗

Summary

The FDA has approved a supplemental application for INDOCIN (indomethacin) by Zyla Life Sciences US LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Gouty Arthritis
• Osteoarthritis
• Patent Ductus Arteriosus
• Rheumatoid Arthritis

Drugs mentioned

• INDOCIN (INDOMETHACIN)

Snippet

SUPPL AP for INDOCIN (INDOMETHACIN)